文献速递其他结缔组织病

系统性硬化症患者血液系统恶性肿瘤风险:瑞典全国登记研究

Haematological malignancies in systemic sclerosis: a population-based nationwide register study.
PubMed 文献 · RMD Open · 2025-11-11

男性风险和发病率最高,18-49岁诊断SSc者超额风险最明显;髓系恶性肿瘤多在SSc诊断前后出现,淋系恶性肿瘤出现较晚。

要点

  • SSc患者血液系统恶性肿瘤风险升高(HR 2.2),B细胞恶性肿瘤风险尤其升高(HR 3.0)。
  • 男性和18-49岁诊断SSc者血液系统恶性肿瘤超额风险最明显。
  • 髓系恶性肿瘤多在SSc诊断前后出现,淋系恶性肿瘤在诊断后数年出现。

核心结论

  • SSc患者血液系统恶性肿瘤风险升高,尤其B细胞恶性肿瘤,男性风险最高。
  • 髓系恶性肿瘤较淋系恶性肿瘤更接近SSc诊断时出现。

研究设计与样本

  • 瑞典全国性队列研究,使用覆盖几乎所有瑞典居民的行政医疗登记数据。
  • 通过瑞典癌症登记识别血液系统恶性肿瘤,采用Poisson回归估计发病率、灵活参数模型估计HR,并按性别和年龄分层。

主要发现

  • SSc患者血液系统恶性肿瘤风险高于无SSc个体(HR 2.2,95%CI 1.4-3.1)。
  • SSc患者B细胞恶性肿瘤风险高于无SSc个体(HR 3.0,95%CI 1.7-4.8)。
  • 男性和SSc诊断时18-49岁者血液系统恶性肿瘤超额风险最明显。
  • 髓系恶性肿瘤在SSc诊断后中位0.1年(IQR 8.2)出现,淋系恶性肿瘤在SSc诊断后中位3.1年(IQR 9.5)出现。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: (1) To assess the risk of haematological malignancies in individuals with systemic sclerosis (SSc) compared with individuals without SSc; (2) to explore how the risk varies across groups stratified by sex and age; and (3) to determine when these malignancies present in relation to SSc diagnosis in a population-based setting. METHODS: We performed a nationwide cohort study using high-quality administrative healthcare registers covering virtually all Swedish residents. All individuals with SSc diagnosed during 2004-2019 and matched general population comparators were included. We identified all haematological malignancies in the study population using the Swedish Cancer Register and estimated the incidence rates using Poisson regression and the HRs using flexible parametric models. We stratified by sex and age and explored the incidence over time since SSc diagnosis. RESULTS: We observed 1720 individuals with incident SSc and 16 983 comparators for 11 480 and 131 021 person-years, respectively. Individuals with SSc had a higher risk of haematological malignancies compared with individuals without SSc (HR 2.2, 95% CI 1.4 to 3.1), especially B-cell malignancies (HR 3.0, 95% CI 1.7 to 4.8). The incidence rate and the HR were highest in men. The SSc over-representation of haematological malignancies was most evident in individuals aged 18-49 years at SSc diagnosis. Myeloid malignancies presented around SSc diagnosis (median 0.1 (IQR 8.2) years after SSc diagnosis) while lymphoid malignancies presented a few years later (median 3.1 (IQR 9.5)). CONCLUSION: Individuals with SSc are afflicted by an increased risk of haematological malignancies, especially B-cell malignancies. The risk is highest in men. Myeloid malignancies tend to present closer to SSc diagnosis than lymphoid malignancies.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Gunnarsson K, Annicchiarico L, Ravn Landtblom A, et al. Haematological malignancies in systemic sclerosis: a population-based nationwide register study. RMD Open. 2025. PMID: 41219126. doi:10.1136/rmdopen-2025-005873

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。